ArticleMolecular and clinical oncology2025
Multicenter validation of CEACAM6 and FOXP3 as robust prognostic biomarkers in colon cancer: Combined immunohistochemical and transcriptomic analysis.
Yingying Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.